MedPath

Formulation of Aftimoon habb and homul Based on Iranian Traditional Pharmacy, Development of Standardization Method and Evaluation of the effect of homul on improving pelvic pain, quality of life and ovarian cyst size in endometriosis patients.

Phase 3
Conditions
Endometriosis.
Endometriosis
Registration Number
IRCT20130911014630N11
Lead Sponsor
Mazandaran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Female
Target Recruitment
68
Inclusion Criteria

Age between 20 to 45
Endometriosis patients with pelvic pain and ovarian cyst over two centimeters
Absence of Müllerian anomaly, fibrosis, adenomyosis and myoma
No medication except NSAIDs for endometriosis within 6 months before referral
Presence of patient's consent to participate in the study

Exclusion Criteria

pregnancy and lactation
Sever and treatment resistant pain which candidates patient for surgary
Absence of any acute and serious liver or kidney disease
Absence of pap smear with intraepithelial pathological changes
No history of any former or being treated malignancy

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Amount of pain. Timepoint: At the beginning of the study, then during the study on period days 3 times a day. Method of measurement: Visual Analog scale.
Secondary Outcome Measures
NameTimeMethod
Size of ovarian cyst. Timepoint: At the beginning of the study, after the first month and after the second month. Method of measurement: Trans-vaginal ultrasound.;Patient quality of life. Timepoint: At the beginning of the study, after the first month and after the second month. Method of measurement: Quality of life Questionnaire EHP30.;Painkiller consumption. Timepoint: At the beginning of the study, after the first month and after the second month. Method of measurement: Questionnaire.
© Copyright 2025. All Rights Reserved by MedPath